|
1
|
Blagosklonny MV and Fojo T: Molecular
effects of paclitaxel: myths and reality (a critical review). Int J
Cancer. 83:151–156. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Neijt JP, Engelholm SA, Tuxen MK, et al:
Exploratory phase III study of paclitaxel and cisplatin versus
paclitaxel and carboplatin in advanced ovarian cancer. J Clin
Oncol. 18:3084–3092. 2000.PubMed/NCBI
|
|
3
|
Chen W, Lu Y, Gao M, Wu J, Wang A and Shi
R: Anti-angiogenesis effect of essential oil from Curcuma zedoaria
in vitro and in vivo. J Ethnopharmacol. 133:220–226. 2011.
View Article : Google Scholar
|
|
4
|
Lobo R, Prabhu KS and Shirwaikar A and
Shirwaikar A: Curcuma zedoaria Rosc. (white turmeric): a review of
its chemical, pharmacological and ethnomedicinal properties. J
Pharm Pharmacol. 61:13–21. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lakshmi S, Padmaja G and Remani P:
Antitumour effects of isocurcumenol isolated from Curcuma zedoaria
rhizomes on human and murine cancer cells. International Journal of
Medicinal Chemistry. 2011:20112011. View Article : Google Scholar
|
|
6
|
Kim KI, Kim JW, Hong BS, et al: Antitumor,
genotoxicity and anticlastogenic activities of polysaccharide from
Curcuma zedoaria. Mol Cells. 10:392–398. 2000.PubMed/NCBI
|
|
7
|
Seo WG, Hwang JC, Kang SK, et al:
Suppressive effect of Zedoariae rhizoma on pulmonary metastasis of
B16 melanoma cells. J Ethnopharmacol. 101:249–257. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shin Y and Lee Y: Cytotoxic activity from
Curcuma zedoaria through mitochondrial activation on ovarian cancer
cells. Toxicol Res. 29:257–261. 2013. View Article : Google Scholar
|
|
9
|
Wu WY, Luo YJ and Cheng JH: Zedoary
turmeric oil inhibits tranplantal hepatoma in rat via hepatic
artery perfusion. Shi Jie Hua Ren Xiao Hua Za Zhi. 11:260–263.
1998.
|
|
10
|
Giampietri A, Bonmassar A, Puccetti P, et
al: Drug-mediated increase of tumor immunogenicity in vivo for a
new approach to experimental cancer immunotherapy. Cancer Res.
41:681–687. 1981.PubMed/NCBI
|
|
11
|
Elmore S: Apoptosis: a review of
programmed cell death. Toxicol Pathol. 35:495–516. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jiang C, Wang Z, Ganther H, et al:
Caspases as key executors of methyl selenium-induced apoptosis
(anoikis) of DU-145 prostate cancer cells. Cancer Res.
61:3062–3070. 2001.PubMed/NCBI
|
|
13
|
Lakhani SA, Masud A, Kuida K, et al:
Caspases 3 and 7: key mediators of mitochondrial events of
apoptosis. Science. 311:847–851. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chowdhry MF, Vohra HA and Galiñanes M:
Diabetes increases apoptosis and necrosis in both ischemic and
nonischemic human myocardium: Role of caspases and poly–adenosine
diphosphate–ribose polymerase. J Thorac Cardiovasc Surg.
134:124–131. 2007. View Article : Google Scholar
|
|
15
|
Chen CC, Chen Y, Hsi YT, et al: Chemical
constituents and anticancer activity of Curcuma zedoaria roscoe
essential oil against non-small cell lung carcinoma cells in vitro
and in vivo. J Agric Food Chem. 61:11418–11427. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chou TC and Talalay P: Quantitative
analysis of dose-effect relationships: the combined effects of
multiple drugs or enzyme inhibitors. Adv Enzyme Regul. 22:27–55.
1984. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Smith RA, Brooks D, Cokkinides V, et al:
Cancer screening in the United States, 2013: a review of current
American Cancer Society guidelines, current issues in cancer
screening, and new guidance on cervical cancer screening and lung
cancer screening. CA Cancer J Clin. 63:87–105. 2013. View Article : Google Scholar
|
|
18
|
McGuire V, Jesser CA and Whittemore AS:
Survival among U.S. woman with invasive epithelical ovarian cancer.
Gynecol Oncol. 84:399–403. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hossein G, Keshavarz M, Ahmadi S and
Naderi N: Synergistic effects of PectaSol-C modified citrus pectin
an inhibitor of Galectin-3 and paclitaxel on apoptosis of human
SKOV-3 ovarian cancer cells. Asian Pac J Cancer Prev. 14:7561–7568.
2013. View Article : Google Scholar
|
|
20
|
Kushner DM, Connor JP, Sanchez F, et al
Wisconsin Oncology Network: Weekly docetaxel and carboplatin for
recurrent ovarian and peritoneal cancer: a phase II trial. Gynecol
Oncol. 105:358–364. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wani MC, Taylor HL, Wall ME, Coggon P and
McPhail AT: Plant antitumor agents. VI. The isolation and structure
of taxol, a novel antileukemic and antitumor agent from Taxus
brevifolia. J Am Chem Soc. 93:2325–2357. 1971. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Maier-Lenz H, Hauns B, Haering B, et al:
Phase I study of paclitaxel administered as a 1-hour infusion:
toxicity and pharmacokinetics. Semin Oncol. 24:S16–S19. 1997.
|
|
23
|
Scripture CD, Figg WD and Sparreboom A:
Peripheral neuropathy induced by paclitaxel: recent insights and
future perspectives. Curr Neuropharmacol. 4:165–172. 2006.
View Article : Google Scholar
|
|
24
|
Cang S, Ma Y, Chiao JW and Liu D:
Phenethyl isothiocyanate and paclitaxel synergistically enhanced
apoptosis and alpha-tubulin hyperacetylation in breast cancer
cells. Exp Hematol Oncol. 3:52014. View Article : Google Scholar :
|
|
25
|
Yang MY, Wang CJ, Chen NF, Ho WH, Lu FJ
and Tseng TH: Luteolin enhances paclitaxel-induced apoptosis in
human breast cancer MDA-MB-231 cells by blocking STAT3. Chem Biol
Interact. 213:60–68. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kang H, Lee SH, Price JE and Kim LS:
Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB in
breast cancer cells and potentiates the growth inhibitory effect of
paclitaxel in a breast cancer nude mice model. Breast J.
15:223–229. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kuo HC, Lee HJ, Hu CC, Shun HI and Tseng
TH: Enhancement of esculetin on Taxol-induced apoptosis in human
hepatoma HepG2 cells. Toxicol Appl Pharmacol. 210:55–62. 2006.
View Article : Google Scholar
|
|
28
|
Long KJ, Han FJ, Wu XK and Wang XY:
Effects of Zedoary turmeric oil injection on SKOV3 cell
proliferation and pathological morphological changes in ovarian
cancer. World Journal of Integrated Traditional and Western
Medicine. 6:660–662. 2011.
|
|
29
|
George J, Banik NL and Ray SK: Molecular
Mechanisms of Taxol for Induction of Cell Death in Glioblastomas.
Glioblastoma: Molecular Mechanisms of Pathogenesis and Current
Therapeutic Strategies. Ray SK: Springer; New York: pp. 283–298.
2010, View Article : Google Scholar
|
|
30
|
Gonçalves A, Braguer D, Carles G, André N,
Prevôt C and Briand C: Caspase-8 activation independent of
CD95/CD95-L interaction during paclitaxel-induced apoptosis in
human colon cancer cells (HT29-D4). Biochem Pharmacol.
60:1579–1584. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Perkins C, Kim CN, Fang G and Bhalla KN:
Overexpression of Apaf-1 promotes apoptosis of untreated and
paclitaxel- or etoposide-treated HL-60 cells. Cancer Res.
58:4561–4566. 1998.PubMed/NCBI
|
|
32
|
Weigel TL, Lotze MT, Kim PK, Amoscato AA,
Luketich JD and Odoux C: Paclitaxel-induced apoptosis in non-small
cell lung cancer cell lines is associated with increased caspase-3
activity. J Thorac Cardiovasc Surg. 119:795–803. 2000. View Article : Google Scholar : PubMed/NCBI
|
